Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep751 | Pituitary and Neuroendocrinology | ECE2022

Immunohistochemichal expression of ephrin receptor (EPH)-A4, -A5, -B2 and -B5 in pituitary lesions

Papadimitriou Eirini , Kyriakopoulos Georgios , Barkas Konstantinos , Gkalonakis Ioannis , Pantoula Panagiota , Theocharis Stamatios , Kaltsas Gregory , Alexandraki Krystallenia

Introduction: Ephrin receptors (EPHs) compose the largest known subfamily of receptors tyrosine kinases and are bound and interact with EPHs-interacting proteins (Ephrins). They have a role in tumor growth, invasion, angiogenesis and metastasis of several neoplasms. Aim of the study was to investigate the expression of EPH-A4, -A5, -B2 and -B5 in pituitary lesions. Material and Methods: Our study group consisted of 18 patients (9 males with median age 54...

ea0081ep1040 | Thyroid | ECE2022

Risk factors for central neck lymph node metastasis in patients with macro and micropapillary thyroid carcinoma

Boutzios Georgios , Chatzi Sofia , Mina Areti , Koukoulioti Eleni , Giovannopoulos Ilias , Tsourouflis Gerasimos

Introduction: The prevalence of lymph node metastasis from micropapillary thyroid carcinoma (mPTC) in different studies is up to 33%. Preoperative diagnosis of central lymph node (CLN) metastasis is essential for the surgical management of those patients. Prophylactic CLN dissection for patients with mPTC is controversial. Our study aimed to assess the prevalence and the risk factors of LMN metastasis in patients mPTC Methods: We retrospectively study th...

ea0050p336 | Obesity and Metabolism | SFEBES2017

Metabolic phenotype of Male Obesity-associated Secondary Hypogonadism pre- and post-replacement therapy with intra-muscular Testosterone undecanoate therapy

Dimitriadis Georgios K , Randeva Harpal S , Grammatopoulos Dimitris K , Barber Thomas M

Aim: To explore the metabolic phenotype of Male Obesity-associated Secondary Hypogonadism (MOSH) and following treatment with long-acting intramuscular (IM) testosterone undecanoate.Methods: A prospective observational pilot study on metabolic effects of IM testosterone undecanoate in MOSH (Hypogonadal [HG] group, n=13), including baseline comparisons with controls (Eugonadal [EG] group, n=15). Half the subj...

ea0050p336 | Obesity and Metabolism | SFEBES2017

Metabolic phenotype of Male Obesity-associated Secondary Hypogonadism pre- and post-replacement therapy with intra-muscular Testosterone undecanoate therapy

Dimitriadis Georgios K , Randeva Harpal S , Grammatopoulos Dimitris K , Barber Thomas M

Aim: To explore the metabolic phenotype of Male Obesity-associated Secondary Hypogonadism (MOSH) and following treatment with long-acting intramuscular (IM) testosterone undecanoate.Methods: A prospective observational pilot study on metabolic effects of IM testosterone undecanoate in MOSH (Hypogonadal [HG] group, n=13), including baseline comparisons with controls (Eugonadal [EG] group, n=15). Half the subj...

ea0086p330 | Metabolism, Obesity and Diabetes | SFEBES2022

Glicentin concentrations following Liraglutide treatment in patients with overweight/obesity

Al-Hasani Wiaam , Ranasinghe Ruvini , Luxton James , Mare Tracey , Dimitriadis Georgios K , Vincent Royce P

Background: Liraglutide is a long-acting glucagon-like peptide-1(GLP-1) receptor agonist that promotes weight loss. The minimum adequate/good response to liraglutide (≥5% weight loss at 3 months) is not achievable in all patients. Currently there are no biomarkers to predict good response. Enhanced postprandial glicentin concentration was recently considered as superior to GLP-1 in predicting weight loss following bariatric surgeries.Objective 1) T...

ea0090p373 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Glycemic control in Type 1 Diabetes patients using multiple daily insulin injections (MDII) vs continuous subcutaneous insulin infusion (CSII)

Tsitsimpis Anastasios , Cherolidi Helen , Kalogeris Nikolaos , Spanou Loukia , Mouslech Tzant , Somali Maria , Georgiopoulos Georgios , Vryonidou Andromachi

Objective: Glycemic control of patients with type 1 diabetes is mainly based on insulin administration. The ongoing technological developments in continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusion (CSII) provide new treatment strategies, with better glycemic control. This study assessed the clinical impact of two treatment strategies in adults with type 1 diabetes (T1D): multiple daily insulin injections (MDII) vs continuous subcutaneous insulin i...

ea0090p231 | Thyroid | ECE2023

Differences between Unilateral and Bilateral Graves’ Orbitopathy. An observational study

Boutzios Georgios , Chatzi Sofia , Mina Areti , Fanouraki Maria , Giovannopoulos Ilias , Karampela Athina , Goules Andreas , Tzioufas Athanasios

Introduction: Graves’ Orbitopathy (GO), the most common extrathyroidal manifestation of Graves’ disease (GD), usually presents bilateral disease. However, a minority of patients present with unilateral disease, the prevalence of which is between 4,5% and 14%. The aim of our study is to evaluate the specific demographic and clinical characteristics and potential differences between bilateral and unilateral GO, and the association with disease activity and severity.</p...

ea0090p516 | Thyroid | ECE2023

Hyalinizing trabecular tumor of the thyroid gland. A rare entity with atypical cytological features A case report

Boutzios Georgios , Tsourouflis Gerasimos , Gakioloulou Charikleia , Destouni Maria , Chatzi Sofia , Giovannopoulos Ilias

Introduction: Hyalinizing trabecular tumors are extremely rare and uncommon thyroid tumors, which were first described by Carney et al. Until now, their preoperative diagnosis based on cytological characteristics is not possible, because of the lack of specific features and molecular markers.Case presentation: We present a 38-year-old Caucasian female, non-smoker, with a disease-free medical history, with a right-sided clearly delimited large hy...

ea0090ep232 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

The effect of glycemic environment on bone mineral density in patients with type 1 diabetes mellitus

Barmpa Eleftheria , Navrozidou Parthena , Vlychou Mariana , Tigas Stilianos , Koukoulis Georgios N. , Bargiota Alexandra

Introduction: Hyperglycemia in type 1 diabetes mellitus (T1DM) is an important determinant of bone health. However, data on the effect of glycemic changes on bone metabolism are limited. The aim of this study was to evaluate BMD in patients with T1DM in relation to changes of glycemic control.Methods/Design: We studied 118 uncomplicated patients with T1DM (GroupD) (mean age: 30.12+8.78years, F/M: 65/53) and 94 healthy controls (GroupC) matched for age, s...

ea0090ep425 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Association of Latent Autoimmune Diabetes of the Adults with other systemic and organ-specific autoimmune diseases

Boutzios Georgios , Chatzi Sofia , Pezoulas Vasileios , Fanouraki Maria , Giovannopoulos Ilias , Androutsakos Theodoros , Koukoulioti Eleni , Goules Andreas

Introduction: Latent autoimmune diabetes of the adults (LADA) is a heterogeneous type of diabetes sharing clinical characteristics of type 2 DM and serum markers of pancreatic autoimmunity detected in type 1 DM. It accounts for 2-12% of all patients with diabetes. The aim of our study is to identify the association between LADA and other systemic or organ-specific autoimmune diseases.Materials and Methods: We conducted an observational study in the outpa...